Cargando…

Persistence of the neutralizing antibody response after SARS-CoV-2 infection

OBJECTIVE: Neutralizing antibodies are among the factors used to measure an individual's immune status for the control of infectious diseases. We aimed to confirm the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody levels in patients who had rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Sang-Mu, Kim, Jun-Won, Jung, Sunhee, Jung, Yujung, Woo, Hye-Min, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695319/ https://www.ncbi.nlm.nih.gov/pubmed/34954127 http://dx.doi.org/10.1016/j.cmi.2021.12.012

Ejemplares similares

Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
por: Kim, Young-Il, et al.
Publicado: (2021)

Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Lee, Beomki, et al.
Publicado: (2022)

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
por: Kim, Cheolmin, et al.
Publicado: (2021)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
por: Ko, Hae Li, et al.
Publicado: (2023)

Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies
por: Vellas, Camille, et al.
Publicado: (2022)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
por: Kwak, Hye Won, et al.
Publicado: (2023)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Outbreak of Rice Blast Disease at Yeoju of Korea in 2020
por: Chung, Hyunjung, et al.
Publicado: (2022)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
por: Decaro, Nicola, et al.
Publicado: (2021)

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Seo, Ji-Min, et al.
Publicado: (2022)

A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
por: Jung, Bo Kyeung, et al.
Publicado: (2021)

Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination
por: Noh, Ji Yun, et al.
Publicado: (2022)

Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection
por: Wisnivesky, Juan P., et al.
Publicado: (2021)

456. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment
por: Ahn, Sangmin, et al.
Publicado: (2023)

Persistence of virus-neutralizing antibodies in horses inoculated with two doses of a live equine herpesvirus type 1 vaccine with different vaccination intervals
por: BANNAI, Hiroshi, et al.
Publicado: (2021)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
por: Haveri, Anu, et al.
Publicado: (2021)

Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19
por: Kim, Yoon-Jung, et al.
Publicado: (2021)

Chromosome-level genome assembly of Plazaster borealis sheds light on the morphogenesis of multiarmed starfish and its regenerative capacity
por: Lee, Yujung, et al.
Publicado: (2022)

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
por: Kim, Sang Il, et al.
Publicado: (2019)

Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study
por: Choi, Min Joo, et al.
Publicado: (2023)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

An Acidic PATHOGENESIS-RELATED1 Gene of Oryza grandiglumis is Involved in Disease Resistance Response Against Bacterial Infection
por: Shin, Sang Hyun, et al.
Publicado: (2014)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
por: Noh, Ji Yun, et al.
Publicado: (2020)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
por: Dispinseri, Stefania, et al.
Publicado: (2021)

Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
por: Roy, Dipa, et al.
Publicado: (2022)

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys
por: In, Hyun Ju, et al.
Publicado: (2018)

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population
por: Lee, Hee-Jung, et al.
Publicado: (2022)

Persistent Environmental Contamination and Prolonged Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea
por: Jeong, Hye Won, et al.
Publicado: (2015)

Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity
por: Kim, Yoonjung, et al.
Publicado: (2022)

Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
por: Lee, Jong-Hwan, et al.
Publicado: (2022)

Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022
por: Lee, Young Jae, et al.
Publicado: (2023)

Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers
por: Lim, Sera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_elmnpu5r8n5ahc2ndotp9if0fe